KMED - KraneShares Emerging Market Healthcare Index ETF
Assets | $5.29M |
NAV | $35.26 |
Expense Ratio | 0.80% |
PE Ratio | 40.21 |
Beta (5Y) | 0.69 |
Dividend (ttm) | $0.01 |
Dividend Yield | 0.02% |
Ex-Dividend Date | Dec 29, 2020 |
1-Year Return | - |
Trading Day | April 20 |
Last Price | $35.03 |
Previous Close | $35.23 |
Change ($) | -0.19 |
Change (%) | -0.55% |
Day's Open | 35.04 |
Day's Range | 35.03 - 35.33 |
Day's Volume | 932 |
52-Week Range | 21.88 - 39.86 |
Fund Description
The investment seeks to provide investment results that, before fees and expenses, track the price and yield performance of the Solactive Emerging Markets Healthcare Index (the index). Under normal circumstances, the fund will invest at least 80% of its total assets in components of the index, depositary receipts, including American depositary receipts (ADRs), representing such components, and securities underlying depositary receipts in the index. The index is a free float adjusted market capitalization weighted index designed to track the equity market performance of emerging market companies engaged in the healthcare business. The fund is non-diversified.
Asset Class Equity | Inception Date Aug 29, 2018 |
Exchange NYSEARCA | Ticker Symbol KMED |
Index Tracked Solactive Emerging Markets Healthcare Index |
Top 10 Holdings
35.89% of assetsName | Symbol | Weight |
---|---|---|
Shenzhen Mindray Bio-Medical Electronics Co Ltd | 300760.SZ | 4.76% |
Celltrion Inc | 068270.KS | 4.41% |
Jiangsu Hengrui Medicine Co Ltd | 600276.SS | 4.36% |
China Evergrande New Energy Vehicle Group Ltd | 708.HK | 3.92% |
Samsung BioLogics Co Ltd | 207940.KS | 3.85% |
WuXi Biologics (Cayman) Inc Registered Shs Unitary 144A/Reg S | 2269.HK | 3.15% |
Sun Pharmaceuticals Industries Ltd | SUNPHARMA.NS | 3.13% |
Chongqing Zhifei Biological Products Co Ltd | 300122.SZ | 3.03% |
Celltrion Healthcare Co Ltd | 091990.KQ | 2.82% |
Aier Eye Hospital Group Co Ltd | 300015.SZ | 2.46% |
Dividends
Ex-Dividend | Amount | Pay Date |
---|---|---|
Dec 29, 2020 | $0.008 | Dec 31, 2020 |
Dec 27, 2019 | $0.379 | Dec 31, 2019 |
Dec 26, 2018 | $0.003 | Dec 28, 2018 |
News
One of the asset classes generating plenty of buzz as a 2021 idea is emerging markets. Up 4.5% over the past month, the MSCI Emerging Markets Index is already pricing in that enthusiasm.